In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $1.74 in the prior trading day, Iovance Biotherapeutics Inc (NASDAQ: IOVA) closed at $1.69, down -2.87%. In other words, the price has decreased by -$2.87 from its previous closing price. On the day, 17.45 million shares were traded. IOVA stock price reached its highest trading level at $1.745 during the session, while it also had its lowest trading level at $1.66.
Ratios:
Our goal is to gain a better understanding of IOVA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 4.18. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 05 ’25 when Kirby Daniel Gordon bought 30,000 shares for $1.84 per share. The transaction valued at 55,200 led to the insider holds 30,000 shares of the business.
Puri Raj K. bought 5,600 shares of IOVA for $9,743 on May 23 ’25. The Chief Regulatory Officer now owns 206,852 shares after completing the transaction at $1.74 per share. On May 14 ’25, another insider, Vogt Frederick G, who serves as the Interim CEO & General Counsel of the company, bought 25,000 shares for $1.69 each. As a result, the insider paid 42,250 and bolstered with 374,646 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IOVA now has a Market Capitalization of 564348480 and an Enterprise Value of 258357120. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.65 while its Price-to-Book (P/B) ratio in mrq is 0.73. Its current Enterprise Value per Revenue stands at 1.215 whereas that against EBITDA is -0.708.
Stock Price History:
The Beta on a monthly basis for IOVA is 0.86, which has changed by -0.7903226 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, IOVA has reached a high of $12.51, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is -27.99%, while the 200-Day Moving Average is calculated to be -71.85%.
Shares Statistics:
The stock has traded on average 13.47M shares per day over the past 3-months and 10851520 shares per day over the last 10 days, according to various share statistics. A total of 333.93M shares are outstanding, with a floating share count of 271.49M. Insiders hold about 18.70% of the company’s shares, while institutions hold 64.00% stake in the company. Shares short for IOVA as of 1749772800 were 90964131 with a Short Ratio of 6.75, compared to 1747267200 on 77018516. Therefore, it implies a Short% of Shares Outstanding of 90964131 and a Short% of Float of 29.830000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
